Skip to main content
Article thumbnail
Location of Repository

Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia

By James D. Heffelfinger, Andrew C. Voetsch, Glenn V. Nakamura, Patrick S. Sullivan, A. D. McNaghten and Laurence Huang
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.
    2. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.
    3. (1999). Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States.
    4. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study.
    5. (2003). Alcohol use disorders: screening and diagnosis.
    6. (1979). Bias in analytic research.
    7. (1980). Can simple clinical measurements detect patient noncompliance?
    8. (2002). Categorical Data Analysis. (Second edition).
    9. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic.
    10. (2004). Current epidemiology of Pneumocystis pneumonia.
    11. (2002). Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.
    12. (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
    13. (2000). Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.
    14. (2000). Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure.
    15. (2001). Factors affecting adherence and convenience in antiretroviral therapy.
    16. (2006). Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase.
    17. (2004). Gender differences in factors associated with adherence to antiretroviral therapy.
    18. (2002). Guidelines for preventing opportunistic infections among HIV-infected persons–2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    19. (2002). HIV-seropositive individuals’ optimistic beliefs about prognosis and relation to medication and safe sex adherence.
    20. (1993). HIV/AIDS Surveillance Report,
    21. (2004). Illicit drug use: can it predict adherence to antiretroviral therapy?
    22. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.
    23. (2000). of Health and Human Services (2000) Healthy People 2010: understanding and improving health. 2nd ed.
    24. (2007). Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
    25. (2004). Patientreported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.
    26. (1988). Projecting the medical costs of AIDS and ARC in the United States.
    27. (2007). Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994–2003.
    28. (1988). Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.
    29. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.
    30. (1996). The supplement to HIV-AIDS Surveillance project: an approach for monitoring HIV risk behaviors.
    31. (2001). Trust and the acceptance of and adherence to antiretroviral therapy.
    32. (1993). When tuberculosis treatment fails. A social behavioral account of patient adherence.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.